Im trying to find clinical info on gardasil I remember a lomg time ago beimg told it was a repurposed drug but cant find it anymore. Also I need info on if it causes infertility.
Comments (2)
sorted by:
Gardasil HPV Vaccine Lawsuit by Ronald V. Miller, Jr.
Our lawyers are helping victims who want to bring a Gardasil HVP vaccine lawsuit throughout the United States. Our law firm is particularly focused on ovarian failure cases that lead to infertility in women who have taken Gardasil in the last few years.
Gardasil is a vaccine intended to prevent human papillomavirus (HPV), which can sometimes lead to cervical cancer in women. Gardasil was developed by the embattled pharmaceutical company Merck & Co.
Merck obtained FDA approval for Gardasil in 2006 based on deceptive research and clinical trials that misrepresented the vaccine’s efficacy while concealing its safety risks and side effects. Merck then launched an aggressive and highly misleading marketing campaign to include millions of parents vaccinating their pre-teen daughters with Gardasil.
Filing a Gardasil lawsuit is not an anti-vax statement. A Gardasil vaccine lawsuit is a statement that this specific vaccine that we all assumed was safe might not be.
You can get a free consultation for your Gardasil claim online.
Gardasil settlement projections for different types of injuries Gardasil Class Action Lawsuit Updates in 2024 September 3, 2024 – Only 3 New Cases in MDL Last 2 Months
The Gardasil class action MDL has only added 3 new cases over the last 2 months. The total number of pending cases in the MDL is now at 200.
August 4, 2024 – Four Cases Dismissed
The MDL judge has dismissed claims from four patients in litigation concerning injuries allegedly caused by Merck’s Gardasil HPV vaccine.
The dismissal was based on procedural grounds related to the National Childhood Vaccine Injury Act, which requires that any vaccine injury claim be first filed with the federal vaccine injury program, known as “Vaccine Court,” within three years of symptom onset. Three plaintiff, filed their petitions too late and failed to appeal the Vaccine Court’s dismissal of their time-barred claims before pursuing civil actions. (The fourth plaintiff did not file a petition at all and did not respond to the motion to dismiss.)
July 18, 2024 – First Gardasil Trial in Two Months
The Gardasil litigation in state court has outpaced in MDL. The first California state trial, Robi v. Merck, is set for October 7, 2024. The plaintiff in that case alleges severe side effects, including heart problems and nerve pain, from the vaccine.
July 1, 2024 – Case Count
This litigation is not exploding. The Gardasil Products Liability Litigation under Judge Kenneth D. Bell in North Carolina saw a minor increase in active cases from 194 in June to 197 in July 2024.
June 12, 2024 – Bellwether Trial Date To Be Set Soon
Lawyers for both sides in the Gardasil HPV vaccine MDL are very close to completing discovery in the initial group of test cases for bellwether trials. The date for the first Gardasil bellwether trial is expected to be set at the MDL status conference set for tomorrow. It seems likely, however, that the first Gardasil test trial will happen in California state court. The California case features a plaintiff who was allegedly left bed-ridden for life as a result of the Gardasil vaccine.
June 3, 2024 – MDL Approaches 200 Cases
There are now 184 total cases pending in the Gardasil class action MDL. Three months ago there were about 140, so this is not a high volume MDL, but it continues grow.
May 20, 2024 – Merck Seeks Dismissal
Last week, Merck moved to dismiss a group of 3 Gardasil cases from the MDL on the grounds that the plaintiffs in each case failed to exhaust their administrative remedies under the National Vaccine Injury Act. The Vaccine Act requires all plaintiffs in vaccine cases to first bring their claims in vaccine court before filing in civil court.
April 5, 2024 – New Case Study
A new case study has highlighted a significant association between Merck’s HPV vaccine, Gardasil, and the development of postural orthostatic tachycardia syndrome (POTS), an autoimmune condition characterized by chronic lightheadedness, fainting, and rapid heartbeat episodes.
Researchers in Utah documented a woman who developed POTS shortly after receiving the Gardasil vaccine in 2014. This case underscores the potential for the vaccine to initiate autoimmune or autonomic dysfunction, possibly as a result of the immune system’s response to a viral component.
This is one more piece of the puzzle linking POTS and the HPV vaccine.
March 29, 2024 – Judge Rules that Gardasil MDL Can Move Forward
Last month, Merck’s defense team filed a motion asking the MDL Judge to dismiss all of the Gardasil lawsuits on the grounds that the failure to warn claims asserted by the plaintiffs are legally barred under the National Childhood Vaccine Injury Act. Last week, however, MDL Judge Kenneth Bell issued a memorandum opinion denying the motion as to failure to warn. Judge Bell found that the claims that Merck negligently failed to warn healthcare providers about the potential risks of Gardasil are not fully barred under the Vaccine Act, nor are claims that Merck fraudulently concealed these risks. This ruling is significant because it clears the way for the Gardasil litigation to move forward into the next phase, which could prompt Merck to seek a global settlement deal.’
March 1, 2024 – 39 Cases Added to MDL Since Start of Year
There are now 143 total cases pending in the Gardasil class action MDL. Since the start of this year, a total of 39 new cases have been added to the MDL.
January 9, 2024 – Status Conference in MDL
Today, Judge Conrad will meet with lawyers about the Gardasil lawsuit. The judge will check on how things are going and listen to both sides about any issues they’re having with gathering information for the case. Before the meeting, both sides agreed on some topics to talk about. They’ll discuss how they plan to share information, give an update from Merck and figure out how to work with similar cases happening in state court in California, and talk about where the Gardasil lawsuits are going in 2024.
They also shared a report saying they’ve finished questioning people about how Merck watched for Gardasil’s side effects and how they tested the drug. They plan to question more people from Merck in the next few months.
The people suing have asked for more documents from Merck, but Merck doesn’t want to give three of those. They’re still trying to work out this disagreement. Big companies do not like to produce documents for one of two reasons: (1) they have something to hide, or (2) they are reflexively oppositional.
Why? You know it's poison.
It's not for me.